1. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. http://aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed 30 Jan 2020.
2. World Health Organization. Update of recommendations on first- and second-line antiretroviral regimens. WHO/CDS/HIV/19.15; Licence: CC BY-NC-SA 3.0 IGO. Geneva: World Health Organization; 2019.
3. Podany AT, Scarsi KK, Fletcher CV. Comparative clinical pharmacokinetics and pharmacodynamics of HIV-1 integrase strand transfer inhibitors. Clin Pharmacokinet. 2017;56(1):25–40.
4. Bictarvey® [package insert]. Foster City (CA): Gilead Sciences; Feb 2018.
5. Zhang HCJ, Wei X, Wang H, Vu A, Ling J, Martin H, et al. Clinical pharmacology of the HIV integrase strand transfer inhibitor bictegravir. Conference on Retroviruses and Opportunistic Infections; Seattle, WA. Feb 13–16, 2017.